Investigating Patient Preferences for Atopic Dermatitis Treatment
Source : https://www.ajmc.com/view/investigating-patient-preferences-for-atopic-dermatitis-treatment
Patient preferences for treatment in adults with atopic dermatitis (AD) highlight the value of oral administration, less frequent monitoring, and rapid onset-even at the expense of reduced efficacy. Study findings...
Conclusion: Regarding patient preferences, participants most valued increasing the chance of achieving a meaningful reduction in itch at week 16 from 20% to 50%, followed by reducing the risks of serious infections from 6% to 0% and of eye inflammation from 20% to 0%.
Examining the Impact of Atopic Dermatitis Severity on Families of Pediatric Patients
Increased atopic dermatitis (AD) severity in pediatric patients was associated with a greater physical, emotional, social, and economic impact on families, according to study findings published in The Journal of...
Discussion: "These results emphasize that the burden of AD and its treatment extends beyond the individual patient and potentially impacts parents and caregivers who are committed to meeting the caregiving needs of their children, especially at higher levels of disease severity,” concluded the study authors.
Efficacy of a 3% Kānuka oil cream for the treatment of moderate-to-severe eczema: A single blind randomised vehicle-controlled trial
Source : https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(22)00291-7/fulltext
The KO group had a significant improvement in POEM score compared to VC. Rates of adverse events and withdrawals were similar between groups with no serious adverse events reported. Treatment...
Discussion: This randomised controlled trial of adults with self-reported moderate to severe eczema, found the use of a kānuka oil cream to be a safe and effective emollient therapy. Both creams were well tolerated by participants, with low rates of adverse events and withdrawals, and positive global acceptability ratings.
Acupuncture and Osteopathic Medicine for Atopic Dermatitis - a Three-armed Randomized Controlled Explorative Clinical Trial - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/35875898/
doi: 10.1111/ced.15340. Online ahead of print. 1 Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Institute of Social Medicine, Epidemiology and Health Economics,...
Conclusion: Although no differences in disease severity were found, our findings indicate that ACU might reduce itching in patients with AD. Furthermore, ACU and OM show a trend toward reducing TCS use.
Overuse of Systemic Corticosteroids, Substantial Cost Burden for AD Seen in Germany
Systemic corticosteroids (SCS) were more commonly prescribed vs other systemic drug options in Germany for patients with atopic dermatitis (AD), with substantial direct and indirect costs cited among these populations....
Conclusion: “The results suggest that the duration of treatment with SCS and their frequent use in nonadult patients exceed the recommendations of current guidelines in the majority of cases. They further suggest a substantial direct and indirect cost burden of patients with AD and SDTI.”